Enzymes that hydrolyze adenine nucleotides in chronic renal failure: Relationship between hemostatic defects and renal failure severity

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1741, Issue 3, 2005, Pages 282-288

  Silva, Adriane C ^a   Morsch, André L B ^a   Zanin, Rafael F ^a   Corrêa, Maísa C ^a   Arantes, Luís C ^a   Araujo, Maria C ^a   Morsch, Vera M ^a   Schetinger, Maria R C ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

5 nucleotidase; Chronic renal failure; Hemodialysis; NTPDase; Platelet

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOTIDE; APYRASE; CREATININE; HYDROLASE; UREA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOSTASIS; HUMAN; HUMAN CELL; HYDROLYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOCYTE; TIME; UREA BLOOD LEVEL;

5'-NUCLEOTIDASE; ADENINE; ANALYSIS OF VARIANCE; ANTIGENS, CD; APYRASE; BLOOD PLATELETS; CREATINE; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; TIME FACTORS; UREA;

EID: 25144524685     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.06.002     Document Type: Article

References (37)

1. M.M. Bern Coagulation and coagulopathies in patients with renal disease M.M. Bern Urinary Tract Bleeding: Diagnosis and Control by Medical, Radiologic and Surgical Techniques 1985 Futura Publishing Co., Inc. Mount Kisco, NY 1 35
2. W.G. Hocking Hematologic abnormalities in patients with renal disease Hematol./Oncol. Clin. North Am. 1 1987 229 260
3. A.C. Carvalho Acquired platelet dysfunction in patients with uremia Hematol/Oncol. Clin. North Am. 4 1990 129 143
4. G. DiMinno, J. Martínez, M. Mckean, J. De La Rosa, J.F. Burke, and S. Murphy Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis Am. J. Med. 79 1985 552 559
5. J. Malyszko, J.S. Malyszko, D. Pawlak, K. Pawlak, W. Buczko, and M. Mysliwiec Hemostasis, platelet function and serotonin in acute and chronic renal failure Thromb. Res. 83 1996 351 361
6. A.J. Marcus, M.J. Broekman, J.H.F. Drosopoulos, N. Islam, D.J. Pinsky, C. Sesti, and R. Levi Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases J. Pharmacol. Exp. Therap. 305 2003 9 16
7. 1 receptor Biochem. Pharmacol. 68 2005 1995 2002
8. N.J. Cusack, and S.M.O. Hourani Platelet P2 receptors: from curiosity to clinical targets J. Autonom. Nerv. Syst. 81 2000 37 43
9. A.J. Marcus, M.J. Broekman, J.H.F. Drosopoulos, N. Islam, D.J. Pinsky, C. Sesti, and R. Levi Heterologous cell-cell interactions:thromboregulation: inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular disease Ital. Heart J. 2 2001 824 830
10. K. Poelstra, J.W. Baller, M.J. Hardonk, and W.W. Bakker Demonstration of antithrombotic activity of glomerular adenosine diphosphatase Blood 78 1991 141 148
11. E. Kaczmarek, K. Koziak, J. Sévigny, J. Siegel, J. Anrather, A. Beaudoin, F. Bach, and S. Robson Identification and characterization of CD39/vascular ATP diphosphohydrolase J. Biol. Chem. 271 1996 33116 33122
12. S.C. Robson, E. Kaczmarek, J.B. Sielgel, D. Candinas, K. Koziak, M. Millan, W.W. Hancock, and F.H. Bach Loss of ATP diphosphohydrolase activity with endothelial cell activation J. Exp. Med. 185 1997 153 163
13. C. Pilla, T. Emanuelli, S.S. Frassetto, A.M.O. Battastini, R.D. Dias, and J.J.F. Sarkis ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets Platelets 7 1996 225 230
14. M. Handa, and G. Guidotti Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (solanum tuberosum) Biochem. Biophys. Res. Commun. 218 1996 916 923
15. D.J. Pinsky, M.J. Broekman, J.J. Peschon, K.L. Stocking, T. Fujita, R. Ramasamy, E.S. Connolly Jr., J. Huang, S. Kiss, Y. Zhang, T.F. Choudhri, R.A. McTaggart, H. Liao, J.H.F. Drosopoulos, V.L. Price, A.J. Marcus, and C.R. Maliszewski Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain J. Clin. Invest. 109 2002 1031 1040
16. J. Sévigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S.C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood 99 2002 2801 2809
17. R.B. Gayle III, C.R. Maliszewski, S.D. Gimpel, M.A. Schoenborn, R.G. Caspary, C. Richards, K. Brasel, V. Price, J.H.F. Drosopoulos, N. Islam, T.N. Alyonycheva, M.J. Broekman, and A.J. Marcus Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39 J. Clin. Invest. 101 1998 1851 1859
18. A. Ramamurthi, R.S. Lewis, and S.C. Robson Effects of nitric oxide (NO) and soluble nucleoside triphosphate diphosphohydrolase (NTPDase) on inhibition of platelet deposition in vitro Thromb. Res. 102 2001 331 341
19. G. Lunkes, D. Lunkes, F. Stefanello, A. Morsch, V.M. Morsch, C.M. Mazzanti, and M.R.C. Schetinger Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies Thromb. Res. 109 2003 89 94
20. K. Enjyoji, J. Sévigny, Y. Lin, P.S. Frenette, P.D. Christie, J.S. Am Esch II, M. Imai, J.M. Edelberg, H. Rayburn, M. Lech, D.L. Beeler, E. Csizmadia, D.D. Wagner, S.C. Robson, and R.D. Rosenberg Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation Nat. Med. 5 1999 1010 1017
21. H. Zimmermann Ectonucleotidases: some recent developments and a note on nomenclature Drug Dev. Res. 52 2001 44 56
22. H. Zimmermann Extracellular purine metabolism Drug Dev. Res. 39 1996 337 352
23. H. Zimmermann, and N. Braun Ecto-nucleotidases-molecular structures, catalytic properties, and functional roles in the nervous system Prog. Brain Res. 120 1999 371 385
24. W. Chen, and G. Guidotti Soluble apyrase release ADP during ATP hydrolysis Biochem. Biophys. Res. Commun. 282 2001 90 95
25. H.J. Agteresch, P.C. Dagnelie, J.W. Van Den Berg, and J.L. Wilson Adenosine triphosphate; established and potential clinical applications Drugs 58 1999 211 232
26. R.E. Lynch, R.H. Bosl, A.J. Streifel, and C.M. Kjellstrand Dialysis thrombocytopenia: parallel plate vs. hollow-fiberdialyzers Trans. - Am. Soc. Artif. Intern. Organ. 24 1978 704 708
27. E.F. Leonard, C. Van Vrooren, D. Hauglustaine, and S. Haumont Shear-rate induced formation of aggregates during hemodialysis Contrib. Nephrol. 36 1983 34 45 (Basel, Karger)
28. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 218 254
29. R. Biggs, and A.S. Douglass The thromboplastin generation test J. Clin. Pathol. 6 1953 23 29
30. D. Heymann, M. Reddington, and G.M. Kreutzberg Subcellular localization of 5′-nucleotidase in rat brain J. Neurochem. 43 1984 971 978
31. 2+-ATPase activity Anal. Biochem. 157 1986 375 380
32. O. Ifudu Care of patients undergoing hemodialysis N. Engl. J. Med. 339 1998 1054 1062
33. S. Pastan, and J. Bailey Dialysis therapy N. Engl. J. Med. 338 1998 1428 1437
34. A.V. Birk, E. Leno, H.D. Robertson, V.M. Bolotina, and H.H. Szeto Interaction between ATP and catecholamines in stimulation of platelets aggregation Am. J. Physiol. 284 2003 H619 H625
35. G.I. Lunkes, D.S. Lunkes, V.M. Morsch, C.M. Mazzanti, A.L. Morsch, V.R. Miron, and M.R.C. Schetinger NTPDase and 5′-nucleotidase activities in rats with alloxan-induced diabetes Diabetes Res. Clin. Pract. 65 2004 1 6
36. Y. Kawashima, T. Nagasawa, and H. Ninomiya Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells Blood 96 2000 2157 2162
37. M.C. Araújo, J.B.T. Rocha, A. Morsch, R. Zanin, R. Bauchspiess, V.M. Morsch, and M.R.C. Schetinger Enzymes that hydrolyze nucleotides in platelets from breast cancer patients Biochem. Biophys. Acta 1740 2005 421 426